Company news
Xintela Ab (OMXSTO:XINT) news
Xintela Ab news releases on 6ix. Latest, Aug 28, 2026: Xintela : Interim Report January – June 2026
Press releases & updates
Xintela : Interim Report January – June 2026
August 28, 2026
Xintela AB Interim Report January - June 2026
August 28, 2026
Xintela publishes safety and efficacy results from knee osteoarthritis clinical study with XSTEM in scientific journal
August 11, 2026
Xintela AB Interim Report January - March 2026
May 29, 2026
Xintela AB changes Certified Adviser to Västra Hamnen Corporate Finance AB
May 28, 2026
Xintela granted patent in Japan for XSTEM® treatment of acute respiratory distress syndrome (ARDS)
May 12, 2026
Xintela AB publishes Annual Report 2025
April 30, 2026
Xintela granted US patent for XSTEM treatment of difficult-to-heal wounds and skin defects
April 14, 2026
Xintela AB Year-end Report 2025
February 27, 2026
Xintela completes clinical study with XSTEM in difficult-to-heal leg ulcers
February 13, 2026
Xintela: Extending the financial runway
December 12, 2025
Xintela: Focus on study results and financing
November 12, 2025
Xintela AB Interim Report January - September 2025
November 4, 2025
Xintela announces subsidiary Targinta collaboration with MSK Therapeutics Accelerator
October 7, 2025
Xintela AB Interim Report January - June 2025
August 29, 2025